Patient: Male, 67-year-old Final Diagnosis: COVID-19 Symptoms: Hypoxia Medication:— Clinical Procedure: Short-term corticosteroid therapy Specialty: Infectious Diseases Objective: Management of emergency care Background: The effect of corticosteroids in the management of patients with coronavirus disease 2019 (COVID-19) is unclear. Case Report: A 67-year-old man who tested positive for COVID-19 by reverse-transcription PCR (RT-PCR) analysis was admitted to our hospital. On admission, he had no dyspnea and his oxygen saturation (SpO 2 ) level was normal. Chest imaging revealed ground-glass opacities (GGO) distributed in both lung fields. Four days after admission, bilateral lung shadows worsened, with a slight reduction in SpO 2 levels. Short-term corticosteroid therapy was initiated, and SpO 2 and radiographic findings promptly improved without use of antiviral agents. Conclusions: More data are required to ascertain the role of corticosteroids in the management of COVID-19 pneumonia.
【저자키워드】 COVID-19, Glucocorticoids, SARS virus, Coronavirus infections, Pneumonia, viral,